Skip to main content
Clinical Trials/IRCT20200111046086N1
IRCT20200111046086N1
Recruiting
Phase 2

A comparison of the effect of Tamsulosin and placebo in the treatment of urinary tract disorder in women

Tabriz University of Medical Sciences0 sites252 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Recruiting
Enrollment
252

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
Female

Inclusion Criteria

  • Women with at least three months of urinary tract disorder
  • Age between 18 to 65 years old
  • Signing informed consent form

Exclusion Criteria

  • Active urinary tract infection
  • History of neurological disorders
  • Pregnant women

Investigators

Similar Trials